BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28143883)

  • 41. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of VEGF and VEGF receptors in childhood precursor B-cell acute lymphoblastic leukemia evaluated by immunohistochemistry.
    Diffner E; Gauffin F; Anagnostaki L; Nordgren A; Gustafsson B; Sander B; Gustafsson B; Persson JL
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):696-701. PubMed ID: 19707156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase.
    Müllers E; Silva Cascales H; Jaiswal H; Saurin AT; Lindqvist A
    Cell Cycle; 2014; 13(17):2733-43. PubMed ID: 25486360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of Cdc20/fizzy negatively regulates the mammalian cyclosome/APC in the mitotic checkpoint.
    Yudkovsky Y; Shteinberg M; Listovsky T; Brandeis M; Hershko A
    Biochem Biophys Res Commun; 2000 May; 271(2):299-304. PubMed ID: 10799291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia.
    Wang F; Demir S; Gehringer F; Osswald CD; Seyfried F; Enzenmüller S; Eckhoff SM; Maier T; Holzmann K; Debatin KM; Wirth T; Meyer LH; Ushmorov A
    Blood; 2018 Jun; 131(26):2929-2942. PubMed ID: 29622548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
    Bassan R; Rohatiner AZ; Lerede T; Di Bona E; Rambaldi A; Pogliani E; Rossi G; Fabris P; Morandi S; Casula P; Carter M; Lambertenghi-Deliliers G; Lister TA; Barbui T
    Hematol J; 2000; 1(4):226-34. PubMed ID: 11920195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional activities of DUX4 fusions in B-cell acute lymphoblastic leukemia.
    Tanaka Y; Kawazu M; Yasuda T; Tamura M; Hayakawa F; Kojima S; Ueno T; Kiyoi H; Naoe T; Mano H
    Haematologica; 2018 Nov; 103(11):e522-e526. PubMed ID: 29773604
    [No Abstract]   [Full Text] [Related]  

  • 48. LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia.
    Fernando TR; Rodriguez-Malave NI; Waters EV; Yan W; Casero D; Basso G; Pigazzi M; Rao DS
    Mol Cancer Res; 2015 May; 13(5):839-51. PubMed ID: 25681502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia.
    Poulard C; Kim HN; Fang M; Kruth K; Gagnieux C; Gerke DS; Bhojwani D; Kim YM; Kampmann M; Stallcup MR; Pufall MA
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3052-3061. PubMed ID: 30733284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.
    Kordes U; Krappmann D; Heissmeyer V; Ludwig WD; Scheidereit C
    Leukemia; 2000 Mar; 14(3):399-402. PubMed ID: 10720133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioinformatics analysis of gene expression profiles in childhood B-precursor acute lymphoblastic leukemia.
    Li J; Zhai X; Wang H; Qian X; Miao H; Zhu X
    Hematology; 2015 Aug; 20(7):377-83. PubMed ID: 25431969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia.
    Qin YZ; Jiang Q; Xu LP; Jiang H; Wang Y; Zhao XS; Li ZR; Lai YY; Liu YR; Zhang XH; Liu KY; Huang XJ
    Ann Hematol; 2019 Nov; 98(11):2551-2559. PubMed ID: 31493003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance.
    Paul MR; Wong V; Aristizabal P; Kuo DJ
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):e546-e549. PubMed ID: 30807395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages.
    McClellan JS; Dove C; Gentles AJ; Ryan CE; Majeti R
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4074-9. PubMed ID: 25775523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does APC/C
    Dohrn MF; Bolaños JP
    J Neurochem; 2019 Oct; 151(1):8-10. PubMed ID: 31441503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
    Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
    Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth.
    Narendran A; Ganjavi H; Morson N; Connor A; Barlow JW; Keystone E; Malkin D; Freedman MH
    Exp Hematol; 2003 Aug; 31(8):693-701. PubMed ID: 12901974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons.
    Gieffers C; Peters BH; Kramer ER; Dotti CG; Peters JM
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11317-22. PubMed ID: 10500174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia.
    Welch MD; Greene WK; Kees UR
    Br J Haematol; 2013 Aug; 162(4):537-41. PubMed ID: 23772794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph
    Vo TT; Lee JS; Nguyen D; Lui B; Pandori W; Khaw A; Mallya S; Lu M; Müschen M; Konopleva M; Fruman DA
    Mol Cancer Ther; 2017 Sep; 16(9):1942-1953. PubMed ID: 28566433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.